Cargando…

A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain

Human parainfluenza virus type 3 (HPIV-3) is one of the most common respiratory viruses particularly among young children and immunocompromised patients. The seasonality, prevalence and genetic diversity of HPIV-3 at a Spanish tertiary-hospital from 2013 to 2015 are reported. HPIV-3 infection was la...

Descripción completa

Detalles Bibliográficos
Autores principales: Godoy, Cristina, Peremiquel-Trillas, Paula, Andrés, Cristina, Gimferrer, Laura, Uriona, Sonia María, Codina, María Gema, Armadans, Lluis, Martín, María del Carmen, Fuentes, Francisco, Esperalba, Juliana, Campins, Magda, Pumarola, Tomàs, Antón, Andrés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127006/
https://www.ncbi.nlm.nih.gov/pubmed/27524509
http://dx.doi.org/10.1016/j.diagmicrobio.2016.07.023
_version_ 1783516267988123648
author Godoy, Cristina
Peremiquel-Trillas, Paula
Andrés, Cristina
Gimferrer, Laura
Uriona, Sonia María
Codina, María Gema
Armadans, Lluis
Martín, María del Carmen
Fuentes, Francisco
Esperalba, Juliana
Campins, Magda
Pumarola, Tomàs
Antón, Andrés
author_facet Godoy, Cristina
Peremiquel-Trillas, Paula
Andrés, Cristina
Gimferrer, Laura
Uriona, Sonia María
Codina, María Gema
Armadans, Lluis
Martín, María del Carmen
Fuentes, Francisco
Esperalba, Juliana
Campins, Magda
Pumarola, Tomàs
Antón, Andrés
author_sort Godoy, Cristina
collection PubMed
description Human parainfluenza virus type 3 (HPIV-3) is one of the most common respiratory viruses particularly among young children and immunocompromised patients. The seasonality, prevalence and genetic diversity of HPIV-3 at a Spanish tertiary-hospital from 2013 to 2015 are reported. HPIV-3 infection was laboratory-confirmed in 102 patients (76%, under 5 years of age). Among <5 years-old patients, 9 (11.5%) were under any degree of immunosuppression, whereas this percentage was significantly higher (19; 79.2%) among patients older than 5 years. HPIV-3 was detected at varying levels, but mainly during spring and summer. All characterized HN/F sequences fell within C1b, C5 and in other two closely C3a-related groups. Furthermore, a new genetic lineage (C1c) was described. Genetic similarity and epidemiological data confirmed some nosocomial infections, highlighting the importance of the HPIV-3 surveillance, particularly in high-risk patients. This study provides valuable information on HPIV-3 diversity due to the scarce information in Europe.
format Online
Article
Text
id pubmed-7127006
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71270062020-04-08 A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain Godoy, Cristina Peremiquel-Trillas, Paula Andrés, Cristina Gimferrer, Laura Uriona, Sonia María Codina, María Gema Armadans, Lluis Martín, María del Carmen Fuentes, Francisco Esperalba, Juliana Campins, Magda Pumarola, Tomàs Antón, Andrés Diagn Microbiol Infect Dis Virology Human parainfluenza virus type 3 (HPIV-3) is one of the most common respiratory viruses particularly among young children and immunocompromised patients. The seasonality, prevalence and genetic diversity of HPIV-3 at a Spanish tertiary-hospital from 2013 to 2015 are reported. HPIV-3 infection was laboratory-confirmed in 102 patients (76%, under 5 years of age). Among <5 years-old patients, 9 (11.5%) were under any degree of immunosuppression, whereas this percentage was significantly higher (19; 79.2%) among patients older than 5 years. HPIV-3 was detected at varying levels, but mainly during spring and summer. All characterized HN/F sequences fell within C1b, C5 and in other two closely C3a-related groups. Furthermore, a new genetic lineage (C1c) was described. Genetic similarity and epidemiological data confirmed some nosocomial infections, highlighting the importance of the HPIV-3 surveillance, particularly in high-risk patients. This study provides valuable information on HPIV-3 diversity due to the scarce information in Europe. Elsevier Inc. 2016-10 2016-07-27 /pmc/articles/PMC7127006/ /pubmed/27524509 http://dx.doi.org/10.1016/j.diagmicrobio.2016.07.023 Text en © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Virology
Godoy, Cristina
Peremiquel-Trillas, Paula
Andrés, Cristina
Gimferrer, Laura
Uriona, Sonia María
Codina, María Gema
Armadans, Lluis
Martín, María del Carmen
Fuentes, Francisco
Esperalba, Juliana
Campins, Magda
Pumarola, Tomàs
Antón, Andrés
A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain
title A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain
title_full A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain
title_fullStr A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain
title_full_unstemmed A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain
title_short A molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in Catalonia, Spain
title_sort molecular epidemiological study of human parainfluenza virus type 3 at a tertiary university hospital during 2013–2015 in catalonia, spain
topic Virology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127006/
https://www.ncbi.nlm.nih.gov/pubmed/27524509
http://dx.doi.org/10.1016/j.diagmicrobio.2016.07.023
work_keys_str_mv AT godoycristina amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT peremiqueltrillaspaula amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT andrescristina amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT gimferrerlaura amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT urionasoniamaria amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT codinamariagema amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT armadanslluis amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT martinmariadelcarmen amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT fuentesfrancisco amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT esperalbajuliana amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT campinsmagda amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT pumarolatomas amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT antonandres amolecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT godoycristina molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT peremiqueltrillaspaula molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT andrescristina molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT gimferrerlaura molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT urionasoniamaria molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT codinamariagema molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT armadanslluis molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT martinmariadelcarmen molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT fuentesfrancisco molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT esperalbajuliana molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT campinsmagda molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT pumarolatomas molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain
AT antonandres molecularepidemiologicalstudyofhumanparainfluenzavirustype3atatertiaryuniversityhospitalduring20132015incataloniaspain